BridgeMD
New treatment option for Type 1 Diabetes
Official title Glu-COACH: a Peer-mentoring Intervention to Reduce Disparities in Continuous Glucose Monitor (CGM) Use
ClinicalTrials.gov ID: NCT06171412
What this study is testing
- What it's testing
- This is a study to develop and evaluate a peer mentoring intervention for Black and Latinx adolescents with type 1 diabetes to increase the initiation and maintenance of a continuous glucose monitoring (CGM) device. This device is a standard of care to improve diabetes management related to diet, exercise, and insulin.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 13 to 21
You may be able to join if
- Diagnosis of type 1 diabetes, as determined clinically by the presence of ketosis or ketoacidosis at presentation and/or the presence of at least one...
- Self-identification as Black and/or Latinx.
- Ability of participant to comprehend and communicate in written and spoken English, in order to complete surveys and participate in mentioning...
- Access to personal cellphone or tablet to participate in remote video sessions with the peer mentor
- using CGM \<50% of the time over the last 3 months
You likely can't join if
- Participants with a prior severe skin reaction to CGM sensor or adhesive.
- Current use of CGM
- Current or planned pregnancy
- Inability to comprehend or communicate in spoken/written English
- people with other medical or mental health conditions that would, in the opinion of the investigators, interfere with the conduct of the study or...
The study team makes the final eligibility decision.
Where it's taking place
- New Haven, Connecticut, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 13 years to 21 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include New Haven, Connecticut, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.